Stem Cell Therapeutic Outcomes Database

ICR 202407-0915-001

OMB: 0915-0310

Federal Form Document

Forms and Documents
Document
Name
Status
Justification for No Material/Nonsubstantive Change
2024-07-24
Justification for No Material/Nonsubstantive Change
2024-07-24
Justification for No Material/Nonsubstantive Change
2024-05-14
Supplementary Document
2024-05-14
Justification for No Material/Nonsubstantive Change
2024-04-08
Justification for No Material/Nonsubstantive Change
2024-04-08
Justification for No Material/Nonsubstantive Change
2024-02-06
Justification for No Material/Nonsubstantive Change
2024-02-06
Supplementary Document
2023-09-20
Supplementary Document
2023-09-20
Justification for No Material/Nonsubstantive Change
2023-09-20
Justification for No Material/Nonsubstantive Change
2023-02-08
Justification for No Material/Nonsubstantive Change
2023-02-08
Supporting Statement A
2022-07-13
Supplementary Document
2022-07-13
Supplementary Document
2022-07-13
Supplementary Document
2022-07-13
Supplementary Document
2022-07-13
Supplementary Document
2022-07-13
Supplementary Document
2022-07-13
ICR Details
0915-0310 202407-0915-001
Active 202405-0915-001
HHS/HSA 21065
Stem Cell Therapeutic Outcomes Database
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 07/25/2024
Retrieve Notice of Action (NOA) 07/25/2024
  Inventory as of this Action Requested Previously Approved
08/31/2025 08/31/2025 08/31/2025
75,101 0 75,101
75,101 0 75,101
0 0 0

The Stem Cell Therapeutic Outcomes Database was established under contract by HRSA to establish and maintain information related to patients who have received stem cell therapeutic products using a standardized, electronic format. Data is collected from transplant centers by the Center for International Blood and Marrow Transplant Research and is used for ongoing analysis of transplant outcomes. HRSA uses the information to carry out its statutory responsibilities. Information is needed to monitor the clinical status of transplantation and to provide the Secretary of HHS with an annual report of transplant center-specific survival data.

US Code: 42 USC 24K, section 379 Name of Law: TRANSPLANT Act of 2021
   PL: Pub.L. 111 - 148 0 Name of Law: TRANSPLANT Act of 2021’’
   PL: Pub.L. 109 - 129 0 Name of Law: The Stem Cell Therapeutic and Research Reauthorization Act of 2010
  
None

Not associated with rulemaking

  87 FR 15439 03/18/2022
87 FR 34692 06/07/2022
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 75,101 75,101 0 0 0 0
Annual Time Burden (Hours) 75,101 75,101 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$4,730,240
No
    No
    No
No
No
No
Yes
Laura Cooper 301 443-2126 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/25/2024


© 2024 OMB.report | Privacy Policy